Skip to main content
Erschienen in: Endocrine 3/2012

01.06.2012 | Original Article

High prevalence of radiological vertebral fractures in HIV-infected males

verfasst von: Carlo Torti, Gherardo Mazziotti, Pier Antonio Soldini, Emanuele Focà, Roberto Maroldi, Daria Gotti, Giampiero Carosi, Andrea Giustina

Erschienen in: Endocrine | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Age-related co-morbidities including osteoporosis are relevant in patients responding to combination antiretroviral therapy (cART). Vertebral fractures are common osteoporotic fractures and their diagnosis is useful for managing at-risk individuals. However, there are few data from HIV-infected patients. Therefore, the aim of this study was to determine the prevalence of and factors associated with vertebral fractures in a population of HIV-infected males. A cross-sectional study of 160 HIV-infected patients with available chest X-rays was conducted from 1998 to 2010. One hundred and sixty-three males with comparable age and with no history of HIV infection were recruited as controls. Semi-quantitative evaluation of vertebral heights in lateral chest X-rays and quantitative morphometry assessment of centrally digitized images using dedicated morphometry software were utilized to detect prevalent vertebral fractures. The result showed that the vertebral fractures were detected in 43/160 (26.9%) HIV-infected patients and in 21/163 (12.9%) controls (P = 0.002). In HIV-infected patients with fractures, 27 had two or more fractures and ten patients had severe fractures. The prevalence of any fractures and multiple fractures in HIV-infected patients receiving cART (29.6 and 20.0%) was slightly higher than in HIV-infected patients not exposed to cART (17.1 and 5.7%), but significantly higher than control subjects (12.9 and 3.7%). At multivariable analyses, body mass index and diabetes mellitus were independently correlated with vertebral fractures in HIV-infected patients. We concluded that a significant proportion of HIV-infected males receiving cART showed vertebral fractures. Furthermore, proactive diagnosis of vertebral fragility fractures is particularly relevant in patients who are overweight or suffer from diabetes.
Literatur
1.
Zurück zum Zitat A.D. Gutierrez, A. Balasubramanyam, Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management. Endocrine (2011). doi:10.1007/s12020-011-9565-7 A.D. Gutierrez, A. Balasubramanyam, Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management. Endocrine (2011). doi:10.​1007/​s12020-011-9565-7
2.
Zurück zum Zitat C. Gazzaruso, R. Bruno, A. Garzaniti et al., Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J. Hypertens. 21(7), 1377–1382 (2003)PubMedCrossRef C. Gazzaruso, R. Bruno, A. Garzaniti et al., Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J. Hypertens. 21(7), 1377–1382 (2003)PubMedCrossRef
3.
Zurück zum Zitat R. Bruno, C. Gazzaruso, P. Sacchi et al., High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk. J. Acquir. Immune Defic. Syndr. 31(3), 363–365 (2002)PubMedCrossRef R. Bruno, C. Gazzaruso, P. Sacchi et al., High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk. J. Acquir. Immune Defic. Syndr. 31(3), 363–365 (2002)PubMedCrossRef
5.
Zurück zum Zitat J.M. Fakruddin, J. Laurence, HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity. Arch. Virol. 150(1), 67–78 (2005)PubMedCrossRef J.M. Fakruddin, J. Laurence, HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity. Arch. Virol. 150(1), 67–78 (2005)PubMedCrossRef
6.
Zurück zum Zitat D. Gibellini, E. de Crignis, C. Ponti et al., HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation. J. Med. Virol. 80(9), 1507–1514 (2008)PubMedCrossRef D. Gibellini, E. de Crignis, C. Ponti et al., HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation. J. Med. Virol. 80(9), 1507–1514 (2008)PubMedCrossRef
7.
Zurück zum Zitat T.T. Brown, R.B. Qaqish, Antiretroviral therapy and the prevalence of osteopenia and ostoporosis: a meta-analytic review. AIDS 20, 2165–2174 (2006)PubMedCrossRef T.T. Brown, R.B. Qaqish, Antiretroviral therapy and the prevalence of osteopenia and ostoporosis: a meta-analytic review. AIDS 20, 2165–2174 (2006)PubMedCrossRef
8.
Zurück zum Zitat B. Young, C.N. Dao, K. Buchacz, R. Baker, J.T. Brooks, Increased rates of bone fracture among HIV-infected persons in the HIV outpatient study (HOPS) compared with the US general population, 2000–2006. Clin. Infect. Dis. 52(8), 1061–1068 (2011)PubMedCrossRef B. Young, C.N. Dao, K. Buchacz, R. Baker, J.T. Brooks, Increased rates of bone fracture among HIV-infected persons in the HIV outpatient study (HOPS) compared with the US general population, 2000–2006. Clin. Infect. Dis. 52(8), 1061–1068 (2011)PubMedCrossRef
9.
Zurück zum Zitat J.A. Womack, J.L. Goulet, C. Gibert, Increased risk of fragility fractures among HIV infected compared to uninfected male. PLoS ONE 6(2), e17217 (2011)PubMedCrossRef J.A. Womack, J.L. Goulet, C. Gibert, Increased risk of fragility fractures among HIV infected compared to uninfected male. PLoS ONE 6(2), e17217 (2011)PubMedCrossRef
10.
Zurück zum Zitat V.A. Triant, T.T. Brown, H. Lee, S.K. Grinspoon, Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J. Clin. Endocrinol. Metab. 93, 3499–3504 (2008)PubMedCrossRef V.A. Triant, T.T. Brown, H. Lee, S.K. Grinspoon, Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J. Clin. Endocrinol. Metab. 93, 3499–3504 (2008)PubMedCrossRef
11.
Zurück zum Zitat J.H. Arnsten, R. Freeman, A.A. Howard et al., Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 21(5), 617–623 (2007)PubMedCrossRef J.H. Arnsten, R. Freeman, A.A. Howard et al., Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 21(5), 617–623 (2007)PubMedCrossRef
12.
Zurück zum Zitat P. Vestergaard, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos. Int. 18(4), 427–444 (2007)PubMedCrossRef P. Vestergaard, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos. Int. 18(4), 427–444 (2007)PubMedCrossRef
13.
Zurück zum Zitat G. Mazziotti, A. Bianchi, S. Bonadonna et al., Prevalence of vertebral fractures in men with acromegaly. J. Clin. Endocrinol. Metab. 93(12), 4649–4655 (2008)PubMedCrossRef G. Mazziotti, A. Bianchi, S. Bonadonna et al., Prevalence of vertebral fractures in men with acromegaly. J. Clin. Endocrinol. Metab. 93(12), 4649–4655 (2008)PubMedCrossRef
14.
15.
Zurück zum Zitat A. Angeli, G. Guglielmi, A. Dovio et al., High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39(2), 253–259 (2006)PubMedCrossRef A. Angeli, G. Guglielmi, A. Dovio et al., High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39(2), 253–259 (2006)PubMedCrossRef
16.
Zurück zum Zitat M. Grigoryan, A. Guermazi, F.W. Roemer, P.D. Delmas, H.K. Genant, Recognizing and reporting osteoporotic vertebral fractures. Eur. Spine J. 12, S104–S112 (2003)PubMedCrossRef M. Grigoryan, A. Guermazi, F.W. Roemer, P.D. Delmas, H.K. Genant, Recognizing and reporting osteoporotic vertebral fractures. Eur. Spine J. 12, S104–S112 (2003)PubMedCrossRef
17.
Zurück zum Zitat G. Mazziotti, E. Canalis, A. Giustina, Drug-induced osteoporosis: mechanisms and clinical implications. Am. J. Med. 123(10), 877–884 (2010)PubMedCrossRef G. Mazziotti, E. Canalis, A. Giustina, Drug-induced osteoporosis: mechanisms and clinical implications. Am. J. Med. 123(10), 877–884 (2010)PubMedCrossRef
18.
Zurück zum Zitat H.K. Genant, M. Jergas, L. Palermo et al., Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 11(7), 984–996 (1996)PubMedCrossRef H.K. Genant, M. Jergas, L. Palermo et al., Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 11(7), 984–996 (1996)PubMedCrossRef
19.
Zurück zum Zitat J.A. Kanis, E.V. McCloskey, H. Johansson, et al., Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK. Osteoporos. Int. 20, 449–502 (2009) J.A. Kanis, E.V. McCloskey, H. Johansson, et al., Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK. Osteoporos. Int. 20, 449–502 (2009)
21.
Zurück zum Zitat N.B. Khazai, G.R. Beck Jr, G.E. Umpierrez, Diabetes and fractures: an overshadowed association. Curr. Opin. Endocrinol. Diabetes Obes. 16, 435–445 (2009)PubMedCrossRef N.B. Khazai, G.R. Beck Jr, G.E. Umpierrez, Diabetes and fractures: an overshadowed association. Curr. Opin. Endocrinol. Diabetes Obes. 16, 435–445 (2009)PubMedCrossRef
22.
Zurück zum Zitat S.K. Grinspoon, A. Carr, Cardiovascular risk and body fat abnormalities in HIV-infected adults. N. Engl. J. Med. 352, 48–62 (2005)PubMedCrossRef S.K. Grinspoon, A. Carr, Cardiovascular risk and body fat abnormalities in HIV-infected adults. N. Engl. J. Med. 352, 48–62 (2005)PubMedCrossRef
23.
Zurück zum Zitat I. Kanazawa, T. Yamaguchi, M. Yamamoto, M. Yamauchi, S. Yano, T. Sugimoto, Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men. Calcif. Tissue Int. 83, 324–331 (2008)PubMedCrossRef I. Kanazawa, T. Yamaguchi, M. Yamamoto, M. Yamauchi, S. Yano, T. Sugimoto, Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men. Calcif. Tissue Int. 83, 324–331 (2008)PubMedCrossRef
24.
Zurück zum Zitat C. De Laet, J.A. Kanis, A. Ode′n et al., Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos. Int. 16, 1330–1338 (2005)PubMedCrossRef C. De Laet, J.A. Kanis, A. Ode′n et al., Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos. Int. 16, 1330–1338 (2005)PubMedCrossRef
25.
Zurück zum Zitat M. Iki , J. Tamaki, Y. Fujita et al., Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos. Int. (2011). doi:10.1007/s00198-011-1733-8 M. Iki , J. Tamaki, Y. Fujita et al., Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos. Int. (2011). doi:10.​1007/​s00198-011-1733-8
26.
Zurück zum Zitat M.P. Dubè, Disorders of glucose metabolism in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 31(6), 1467–1475 (2000)PubMedCrossRef M.P. Dubè, Disorders of glucose metabolism in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 31(6), 1467–1475 (2000)PubMedCrossRef
27.
Zurück zum Zitat T.T. Brown, M.D. Ruppe, R. Kassner et al., Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. J. Clin. Endocrinol. Metab. 89(3), 1200–1206 (2004)PubMedCrossRef T.T. Brown, M.D. Ruppe, R. Kassner et al., Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. J. Clin. Endocrinol. Metab. 89(3), 1200–1206 (2004)PubMedCrossRef
28.
Zurück zum Zitat D.M. Wunder, N.A. Bersinger, C.A. Fux et al., Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antivir. Ther. 12, 261–265 (2007)PubMed D.M. Wunder, N.A. Bersinger, C.A. Fux et al., Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antivir. Ther. 12, 261–265 (2007)PubMed
29.
Zurück zum Zitat J.E. Gallant, S. Staszewski, A.L. Pozniak et al., Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naïve patients: a 3-year randomized trial. JAMA 292(2), 191–201 (2004)PubMedCrossRef J.E. Gallant, S. Staszewski, A.L. Pozniak et al., Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naïve patients: a 3-year randomized trial. JAMA 292(2), 191–201 (2004)PubMedCrossRef
30.
Zurück zum Zitat G.A. McComsey, D. Kitch, E.S. Daar et al., Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS Clinical Trials Group A5224s, a substudy of ACTG A5202. J. Infect. Dis. 203(12), 1791–1801 (2011)PubMedCrossRef G.A. McComsey, D. Kitch, E.S. Daar et al., Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS Clinical Trials Group A5224s, a substudy of ACTG A5202. J. Infect. Dis. 203(12), 1791–1801 (2011)PubMedCrossRef
Metadaten
Titel
High prevalence of radiological vertebral fractures in HIV-infected males
verfasst von
Carlo Torti
Gherardo Mazziotti
Pier Antonio Soldini
Emanuele Focà
Roberto Maroldi
Daria Gotti
Giampiero Carosi
Andrea Giustina
Publikationsdatum
01.06.2012
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2012
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9586-7

Weitere Artikel der Ausgabe 3/2012

Endocrine 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.